<DOC>
	<DOCNO>NCT02116972</DOCNO>
	<brief_summary>This study double-blind , randomize , parallel group , dose-ranging , single dose design . The study conduct male female patient ≥ 40 year age osteoarthritis ( OA ) knee . Approximately 300 patient OA knee randomize one three treatment group ( 1:1:1 ) treat single intra-articular ( IA ) injection : - 20 mg FX006 , - 40 mg FX006 , - normal saline . Each patient evaluate total 24 week follow single IA injection . Following screening , safety efficacy evaluate 6 out-patient visit ( Days 1 [ Baseline ] , Weeks 4 , 8 , 12 , 16 , 20 24 ) .</brief_summary>
	<brief_title>Study FX006 v Normal Saline Patients With Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Main Willingness ability comply study procedure visit schedule ability follow verbal write instruction Male female &gt; =40 year age Has document diagnosis OA index knee make least 6 month prior Screening Currently meet American College Rheumatology ( ACR ) Criteria ( clinical radiological ) OA KellgrenLawrence ( KL ) Grade 2 3 index knee per Screening Xray Qualifying mean score 24h average pain score ( 010 numeric rating scale ) Body mass index ( BMI ) ≤ 40 kg/m2 Willingness abstain use restrict medication Main Ipsilateral hip OA Fibromyalgia , chronic pain syndrome concurrent medical arthritic condition could interfere evaluation index knee History Reiter 's syndrome , rheumatoid arthritis , psoriatic arthritis , ankylose spondylitis , arthritis associate inflammatory bowel disease , sarcoidosis amyloidosis History arthritides due crystal ( e.g. , gout , pseudogout ) History clinical sign symptom infection index joint Knee pain clinically attributable OA knee ( e.g. , radicular low back pain hip pain refer knee could cause misclassification ) Pain area low extremity back equal great index knee pain IA corticosteroid ( investigational market ) joint within 3 month Screening IA hyaluronic acid ( investigational market ) index knee within 6 month Screening Intramuscular ( IM ) corticosteroid ( investigational market ) within 3 month Screening Oral corticosteroid ( investigational market ) within 1 month Screening Inhaled , intranasal topical corticosteroid ( investigational market ) within 2 week Screening Any IA investigational drug/biologic within 6 month Screening Prior use FX006 Women childbearing potential use effective contraception pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Knee</keyword>
	<keyword>pain</keyword>
	<keyword>steroid</keyword>
	<keyword>intra-articular</keyword>
	<keyword>injection</keyword>
</DOC>